By Nono Hu, Director of Marketing, LSN
RESI JPM 2019 was the biggest Redefining Early Stage Investments event yet. In a highly competitive RESI Innovation Challenge we saw novel technologies represented from the therapeutics, medtech, diagnostics, and digital health verticals - we know it was tough for RESI attendees to choose how to allocate their 5 RESI "investment" tokens! We wish all our finalists the best in bringing their products forward toward commercialization, but there could only be 3 top prize winners.
|
Jonathan Oron,VP R&D, Novotalk | Lilach Shvimer-Rothschild, Co-founder & COO, Novotalk | Dennis Ford, Founder & CEO, Life Science Nation | Zohar Beeri, CEO, Novotalk | Karen Deyo, Investor Research Analyst, Life Science Nation |
|
Fushun Hsu, CEO, Heroic-Faith Medical Science | Yuan-Ren Cheng, COO, Heroic-Faith Medical Science | Dennis Ford, Founder & CEO, Life Science Nation | Lucy Parkinson, VP of Investor Research, Life Science Nation |
|
Rune Wiik Kristensen, COO, MedTrace | Martin Stenfeldt, CEO, MedTrace | Dennis Ford, Founder & CEO, Life Science Nation | Lucy Parkinson, VP of Investor Research, Life Science Nation |
|